Press Release: Biograil and Lilly Sign Collaboration and License Agreement
Biograil has signed a Collaboration and License Agreement with Eli Lilly
Author: Karsten Lindhardt
Press Release: Biograil Receives Innobooster Grant Providing Non-dilutive funding for BIONDDTM Technology Research and Activities in Preparations for Phase 1 clinical trials
Biograil recieves granting of government funds from Innobooster
Press Release: Biograil Forms International Scientific Advisory Board with Diverse Expertise to Support Further Optimization of the proprietary BIONDDTM Technology
After achieving proof of concept of BIONDDTM Technology in a pre-clinical model
Press Release: Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics
Biograil closing of a Seed 2 funding of 3.2 million Euro.
Press Release: Biograil signs collaboration agreement with Janssen
Biograil has signed a Feasibility, Option and License Agreement with Janssen Biotech, Inc.
Press Release: Biograil announces – Sanner Ventures has joined Investor Syndicate
Biograil closing of a seed funding of 3 Million Euro
CEO Karsten Lindhardt shares vision for Biograil, by MEGATREND INVEST
CEO Karsten Lindhardt shares vision for Biograil, by MEGATREND INVEST
Press Release: Biograil Secures Seed Funding for Oral Delivery Device with Potential to Transform Market for Injectables
Biograil closing of a seed funding of 3 Million Euro